Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,258) with videos related to
Page
of 126
Sort By:
Oncotarget
|
March 22, 2021
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians
Julie Guibon, Pierre-Emmanuel Sugier, Om Kulkarni, et al.
Plos One
|
December 17, 2011
Genome characterization of the oleaginous fungus Mortierella alpina
Lei Wang, Wei Chen, Yun Feng, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
|
May 11, 2010
[Test-retest reliability of Mandarin monosyllable lists: a multi-center study in Chinese dialectal regions]
Fei Ji, Xin Xi, Dong-yi Han, et al.
Plant Communications
|
December 18, 2024
Genomic analysis of Zhou8425B, a key founder parent, reveals its genetic contributions to elite agronomic traits in wheat breeding
Guangwei Li, Yan Ren, Yuxin Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 20, 2023
Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study
Chao Liu, Yu-Ping Zhou, Tian-Yu Lian, et al.
Nature Communications
|
August 9, 2022
Connecting omics signatures and revealing biological mechanisms with iLINCS
Marcin Pilarczyk, Mehdi Fazel-Najafabadi, Michal Kouril, et al.
Gastroenterology
|
April 19, 2026
Pre-Crohn's Disease Stool from Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice
Cong Phi Dang, Alice Chen-Liaw, Mingyue Xue, et al.
Iscience
|
January 20, 2023
Sex differences in the oral microbiome, host traits, and their causal relationships
Xiaomin Liu, Xin Tong, Zhuye Jie, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2021
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
Yuming Li, Guixue Hou, Haibo Zhou, et al.
Journal of Hepatology
|
July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial
Qi Xu, Shurui Zhou, Chenbo Zhang, et al.
Page
of 126
Search research articles
Search
Showing results (1231-1240 of 1,258) with videos related to
Sort By:
Page
of 126
Oncotarget
|
March 22, 2021
Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians
Julie Guibon, Pierre-Emmanuel Sugier, Om Kulkarni, et al.
Plos One
|
December 17, 2011
Genome characterization of the oleaginous fungus Mortierella alpina
Lei Wang, Wei Chen, Yun Feng, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
|
May 11, 2010
[Test-retest reliability of Mandarin monosyllable lists: a multi-center study in Chinese dialectal regions]
Fei Ji, Xin Xi, Dong-yi Han, et al.
Plant Communications
|
December 18, 2024
Genomic analysis of Zhou8425B, a key founder parent, reveals its genetic contributions to elite agronomic traits in wheat breeding
Guangwei Li, Yan Ren, Yuxin Yang, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 20, 2023
Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study
Chao Liu, Yu-Ping Zhou, Tian-Yu Lian, et al.
Nature Communications
|
August 9, 2022
Connecting omics signatures and revealing biological mechanisms with iLINCS
Marcin Pilarczyk, Mehdi Fazel-Najafabadi, Michal Kouril, et al.
Gastroenterology
|
April 19, 2026
Pre-Crohn's Disease Stool from Discordant Siblings Promotes the Development of Colitis in Germ-Free Mice
Cong Phi Dang, Alice Chen-Liaw, Mingyue Xue, et al.
Iscience
|
January 20, 2023
Sex differences in the oral microbiome, host traits, and their causal relationships
Xiaomin Liu, Xin Tong, Zhuye Jie, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2021
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery
Yuming Li, Guixue Hou, Haibo Zhou, et al.
Journal of Hepatology
|
July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial
Qi Xu, Shurui Zhou, Chenbo Zhang, et al.
Page
of 126